FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Tina-quant Cystatin C Gen.2

K Number: K161817 · Decision Jul 27, 2016
Classifications
1
FEI Numbers
24
Registration Numbers
24
Same Product Code
21
Applicant Total
14
Review Days
26

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Tina-quant Cystatin C Gen.2
K Number
K161817
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
862.1225
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics Operations (Rdo)
Date Received
July 1, 2016
Decision Date
July 27, 2016
Product Code
NDY
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NDY Test, Cystatin C

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NDY), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics Operations (Rdo)

K Number Device Name
K193053 Tina-quant Hemoglobin A1cDx Gen.3
K192072 Tina-quant C-Reactive Protein IV
K183517 Ammonia II
K182095 Tina-quant Transferrin ver.2 (urine application)
K171080 ALP IFCC Gen.2
K160571 cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay
K162593 HDL-Cholesterol Gen.4
K160570 Creatine Kinase
K152245 ONLINE TDM Vancomycin Gen.3
K151578 Carbamazepine Gen 4
Search all 14 clearances from Roche Diagnostics Operations (Rdo) →